Abstract
The gut microbiota plays significant roles in the human body during all spheres’ of life and influences innate immunity, promotes granulocyte signaling and provides resistance during pathogenic colonization of the gut; crucial for a healthy life. Antibiotics directly affect the gut microbiota that consequently alters the basic biological processes and imposes severe consequences in population falling under different age groups. In this article, we assessed the differences in microbial colonization and immune function of the intestinal tract in infants, adults, and the aged people and also examined the recent reports describing the impacts of antibiotics on infant microbiome assembly and functioning. The age old techniques have been compared to modern ones in relation to the functioning of the gut microbiome to draw inferences on significant impacts of various microbiota on human life starting from the womb, through infancy, adulthood and old age. It was observed that data is limited to different classes or origin of populace depicting variations in food habits and/or suffering from heavy metal associated diseases after continuous exposure to heavy metals/ metalloids/ biocides. Such extreme environmental factors significantly modulate the microbiota and assist in creating a 'co-resistant' gene pool that influences gut health. In the light of this finding, it is important to analyze the ‘co-resistant’ gene pool existing in gut-microbiome which supports to recoup and establish a healthy life. The hypothesis of ‘postbiotics’ is under process and their associations with antibiotic turn to be new-insight in antibiotic therapy. On one hand, postbiotics provide a great opportunity to understand the mechanism of action against pathobionts; on the other; they lead to postulation of newer pharmabiotic products and pharmacological strategies for better gut health.
Keywords: Antibiotics, antibiotic resistant genes, analysis methods, gut microbiome, postbiotics, co-resistant.
Current Pharmaceutical Design
Title:Antibiotics Associated Disorders and Post-biotics Induced Rescue in Gut Health
Volume: 24 Issue: 7
Author(s): Debarati Paul, Sounik Manna and Santi M. Mandal*
Affiliation:
- Central Research Facility, Indian Institute of Technology Kharagpur, Kharagpur 721302, WB,India
Keywords: Antibiotics, antibiotic resistant genes, analysis methods, gut microbiome, postbiotics, co-resistant.
Abstract: The gut microbiota plays significant roles in the human body during all spheres’ of life and influences innate immunity, promotes granulocyte signaling and provides resistance during pathogenic colonization of the gut; crucial for a healthy life. Antibiotics directly affect the gut microbiota that consequently alters the basic biological processes and imposes severe consequences in population falling under different age groups. In this article, we assessed the differences in microbial colonization and immune function of the intestinal tract in infants, adults, and the aged people and also examined the recent reports describing the impacts of antibiotics on infant microbiome assembly and functioning. The age old techniques have been compared to modern ones in relation to the functioning of the gut microbiome to draw inferences on significant impacts of various microbiota on human life starting from the womb, through infancy, adulthood and old age. It was observed that data is limited to different classes or origin of populace depicting variations in food habits and/or suffering from heavy metal associated diseases after continuous exposure to heavy metals/ metalloids/ biocides. Such extreme environmental factors significantly modulate the microbiota and assist in creating a 'co-resistant' gene pool that influences gut health. In the light of this finding, it is important to analyze the ‘co-resistant’ gene pool existing in gut-microbiome which supports to recoup and establish a healthy life. The hypothesis of ‘postbiotics’ is under process and their associations with antibiotic turn to be new-insight in antibiotic therapy. On one hand, postbiotics provide a great opportunity to understand the mechanism of action against pathobionts; on the other; they lead to postulation of newer pharmabiotic products and pharmacological strategies for better gut health.
Export Options
About this article
Cite this article as:
Paul Debarati , Manna Sounik and Mandal M. Santi *, Antibiotics Associated Disorders and Post-biotics Induced Rescue in Gut Health, Current Pharmaceutical Design 2018; 24 (7) . https://dx.doi.org/10.2174/1381612824666171227221731
DOI https://dx.doi.org/10.2174/1381612824666171227221731 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aspergillus – Classification and Antifungal Susceptibilities
Current Pharmaceutical Design Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion
Current Vascular Pharmacology Migraine and Central Sensitization: Clinical Features, Main Comorbidities and Therapeutic Perspectives
Current Rheumatology Reviews Convection Enhanced Drug Delivery of Novel Therapeutic Agents to Malignant Brain Tumors
Current Drug Delivery Cefepime and its Role in Pediatric Infections
Recent Patents on Anti-Infective Drug Discovery Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Novel AβIsoforms in Alzheimer's Disease - Their Role in Diagnosis and Treatment
Current Pharmaceutical Design Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006
Endocrine, Metabolic & Immune Disorders - Drug Targets West Nile Virus Vaccine.
Current Drug Targets - Infectious Disorders The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets Coagulation and Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Intestinal Parasite Infestation in HIV Infected Patients
Current HIV Research Antibacterial Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles Towards Streptococcus agalactiae
Current Pharmaceutical Biotechnology Clearance of Beta-Amyloid in the Brain
Current Medicinal Chemistry Evaluation of B Lymphocyte Deficiencies
Cardiovascular & Hematological Disorders-Drug Targets Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research Effect of Immunoglobulin Therapy on Blood Viscosity and potential concerns of Thromboembolism, Especially in Patients with Acute Kawasaki Disease
Recent Patents on Cardiovascular Drug Discovery GqPCR-mediated Signalling in the Spotlight: From Visualization Towards Dissection and Quantification
Current Pharmaceutical Biotechnology Aligning Animal Models of Clinical Germinal Matrix Hemorrhage, From Basic Correlation to Therapeutic Approach
Current Drug Targets Metabolomics: A Revolution for Novel Cancer Marker Identification
Combinatorial Chemistry & High Throughput Screening